BerandaORXOY • OTCMKTS
add
Orexo AB - ADR
Tutup sebelumnya
$1,99
Rentang tahun
$0,89 - $1,99
Kapitalisasi pasar
73,84 jt USD
Volume Rata-Rata
39,00
Rasio P/E
-
Hasil dividen
-
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (SEK) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 118,20 jt | -23,25% |
Biaya operasional | 128,10 jt | -18,09% |
Laba bersih | -39,80 jt | -10,86% |
Margin laba bersih | -33,67 | -44,44% |
Penghasilan per saham | -1,15 | -10,58% |
EBITDA | -6,90 jt | -428,57% |
Tarif pajak efektif | -17,40% | — |
Neraca
Total aset
Total liabilitas
| (SEK) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 121,30 jt | -13,17% |
Total aset | 533,40 jt | -31,02% |
Total liabilitas | 730,40 jt | -2,50% |
Total ekuitas | -197,00 jt | — |
Saham yang beredar | 34,71 jt | — |
Harga terhadap nilai buku | -0,35 | — |
Tingkat pengembalian aset | -8,61% | — |
Tingkat pengembalian modal | -14,73% | — |
Arus Kas
Perubahan kas bersih
| (SEK) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -39,80 jt | -10,86% |
Kas dari operasi | -700,00 rb | 89,23% |
Kas dari investasi | — | — |
Kas dari pembiayaan | 4,50 jt | 109,38% |
Perubahan kas bersih | 2,20 jt | 103,77% |
Arus kas bebas | 36,26 jt | 894,79% |
Tentang
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
Didirikan
1995
Situs
Karyawan
110
